439 related articles for article (PubMed ID: 29526276)
21. How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?
Quinn GR; Singer DE; Chang Y; Go AS; Borowsky LH; Fang MC
Am J Cardiol; 2016 Sep; 118(5):697-9. PubMed ID: 27394408
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
Zhu WG; Xiong QM; Hong K
Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
[TBL] [Abstract][Full Text] [Related]
23. CHA
Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
[TBL] [Abstract][Full Text] [Related]
24. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
Hilkens NA; Algra A; Greving JP
Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618
[TBL] [Abstract][Full Text] [Related]
25. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation.
Kjerpeseth LJ; Ellekjær H; Selmer R; Ariansen I; Furu K; Skovlund E
Eur J Clin Pharmacol; 2018 Dec; 74(12):1653-1662. PubMed ID: 30116828
[TBL] [Abstract][Full Text] [Related]
27. [A comparison of CAS risk model and CHA
Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706
[No Abstract] [Full Text] [Related]
28. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.
Yao X; Abraham NS; Alexander GC; Crown W; Montori VM; Sangaralingham LR; Gersh BJ; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26908412
[TBL] [Abstract][Full Text] [Related]
29. Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study.
Wang SV; Franklin JM; Glynn RJ; Schneeweiss S; Eddings W; Gagne JJ
BMJ; 2016 May; 353():i2607. PubMed ID: 27221664
[TBL] [Abstract][Full Text] [Related]
30. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
31. Warfarin therapy for atrial fibrillation in general practice--is bleeding risk underestimated?
Bratland B; Hornnes MB
Tidsskr Nor Laegeforen; 2014 Jan; 134(2):175-9. PubMed ID: 24477151
[TBL] [Abstract][Full Text] [Related]
32. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
Proietti M; Rivera-Caravaca JM; Esteve-Pastor MA; Marín F; Lip GYH
Thromb Haemost; 2021 Aug; 121(8):1107-1114. PubMed ID: 33296920
[TBL] [Abstract][Full Text] [Related]
33. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
34. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
35. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
[TBL] [Abstract][Full Text] [Related]
36. Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Marín F; Lip GYH
Am Heart J; 2018 Mar; 197():27-34. PubMed ID: 29447781
[TBL] [Abstract][Full Text] [Related]
37. Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
Chan YH; Yeh YH; See LC; Wang CL; Chang SH; Lee HF; Wu LS; Tu HT; Kuo CT
J Am Coll Cardiol; 2016 Nov; 68(21):2272-2283. PubMed ID: 27884245
[TBL] [Abstract][Full Text] [Related]
38. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634
[TBL] [Abstract][Full Text] [Related]
39. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
Wilson D; Ambler G; Shakeshaft C; Brown MM; Charidimou A; Al-Shahi Salman R; Lip GYH; Cohen H; Banerjee G; Houlden H; White MJ; Yousry TA; Harkness K; Flossmann E; Smyth N; Shaw LJ; Warburton E; Muir KW; Jäger HR; Werring DJ;
Lancet Neurol; 2018 Jun; 17(6):539-547. PubMed ID: 29778365
[TBL] [Abstract][Full Text] [Related]
40. Impact of renal function deterioration on adverse events during anticoagulation therapy using non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Miyamoto K; Aiba T; Arihiro S; Watanabe M; Kokubo Y; Ishibashi K; Hirose S; Wada M; Nakajima I; Okamura H; Noda T; Nagatsuka K; Noguchi T; Anzai T; Yasuda S; Ogawa H; Kamakura S; Shimizu W; Miyamoto Y; Toyoda K; Kusano K
Heart Vessels; 2016 Aug; 31(8):1327-36. PubMed ID: 26276272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
